Interested in a specialized area of hepatology? Join TLMdX's SIG sessions to exchange ideas with experts on trending topics. Sessions include:
The Changing Role of Transplant in Acute-on-Chronic Liver Failure | Acute-on-Chronic Liver Failure SIG
What is the role of organ transplantation in the care of acute on chronic liver failure (ACLF)? This program was designed to thoroughly review the management of the ACLF patient awaiting liver transplantation (LT), and to examine recently published data on patient outcomes. Post-LT complications and the evolving role of palliative care in patients listed for LT will be explored.
- Review the management of the ACLF patient awaiting liver transplantation and articulate appropriate treatment goals.
- Describe the implications of ACLF and multi-organ dysfunction on post-liver transplantation outcomes.
- Understand the evolving role of palliative care in the patient ACLF patient listed for liver transplantation.
New Frontiers in PSC | Cholestatic and Autoimmune Liver Diseases SIG
In this program, experts in the field will address important, yet often controversial, topics in the management of patients with cholangiopathies. The session will focus in particular on primary sclerosing cholangitis (PSC). Clinicians will learn about emerging developments in potential medical therapies, as well as improved monitoring techniques and surveillance strategies for the ongoing care of their patients.
- Review the impact of gut microbiome in PSC and future interventions designed to manipulate the microbiome in this disease.
- Describe differences in clinical presentation and management between pediatric and adult patients with PSC.
- Appraise a differential diagnosis and management plan for patients with cholangiopathies.
- Interpret and apply novel imaging methods in patients with PSC.
- Design an appropriate surveillance strategy for cholangiocarcinoma in patients with PSC.
Cellular Senescence in Liver Disease and Aging | Liver Cell Biology in Hepatic Diseases SIG
Cellular senescence is a cell cycle arrest program often accompanied by secretion of proinflammatory cytokines and mitochondrial dysfunction. Senescent cells contribute to age-related tissue degradation and may be involved in the pathogenesis of HCC, fibrosis and cholangiopathies. This symposium will explore how experts are working to translate basic science discoveries into emerging therapeutic strategies for several liver diseases.
- Discuss the basic concepts of cellular senescence.
- Recognize the role of cellular senescence in the regulation of liver cell function in health and diseases.
- Describe the impact of cellular senescence on tumor microenvironment and age-related progression of liver diseases.
- Identify senescence-based therapeutic strategies for liver diseases.
Controversies in the Diagnosis and Management of Non-cirrhotic Portal Hypertension in Children and Adults | Pediatric Liver Disorders SIG & Portal Hypertension SIG (Part 2)
This two-session program explores non-cirrhotic portal hypertension in both children and adults. The first session covers the definition/nomenclature and diagnostic strategies for non-cirrhotic portal hypertension. The second session explores monitoring and management of children and adults with non-cirrhotic portal hypertension, including medical, interventional radiology and surgical challenges. Each session includes case presentations to highlight controversies, expert panel interviews and Q&A.
- Review the definition, nomenclature and diagnostic approach for non-cirrhotic portal hypertension.
- Review the similarities and differences in the etiology of non-cirrhotic portal hypertension in pediatric and adult populations.
- Discuss the indications for treatment strategies, including medical, radiologic and surgical intervention of non-cirrhotic portal hypertension in children and adults.
Patient-centered Care: An Evolving Paradigm for Chronic Liver Diseases | Public Health/Health Care Delivery SIG
This program closely examines key components of patient-centered care, including integration of patient-reported outcomes within routine care, care coordination and palliative care integration, telehealth, and emerging models for screening and linkage to care. Speakers will discuss how these care models inform providers in hepatology and how value-based approaches can further consolidate recent arguments to improve chronic liver disease care.
- Review the key components of patient-centered care for the chronic liver disease population and strategies to bring these components to routine hepatology practice.
- Discuss necessary changes to enhance patient-centeredness within routine practice.
- Describe ways that the emerging domains of patient-centered care can bring out positive changes not only in clinical services but also patient outcomes.